8-K4.015.029.01
AND EXCHANGE COMMISSION
BRTX: AND EXCHANGE COMMISSION
EDGARBRTX: AND EXCHANGE COMMISSION
BioRestorative Therapies Inc (BRTX) just filed. BRTX: AND EXCHANGE COMMISSION (8-K 2026-09-01).
Those exhibit numbers sit next to the income-statement cache: Latest reported BRTX revenue for 2025-09-30 was $11.8K. Net income was -$3.0M. Revenue was down 96.1% from 2025-06-30 to 2025-09-30. BRTX currently screens at market cap $10.2M. The BRTX filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what BioRestorative Therapies Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
8-KEX-99.14.015.029.01
AND EXCHANGE COMMISSION
BRTX: AND EXCHANGE COMMISSION
Source on EDGAR0
10-K
0
10-Q
3
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all BRTX filings.
Frequently asked questions
What did BRTX just say?
BRTX: AND EXCHANGE COMMISSION
Where are BRTX SEC filings?
3 cached filings are on this page. EDGAR remains the official archive (CIK 0001505497).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.